StarZero All shows Try the podcast clipper →

Mar 3, 2025 · 30m · the-pitch

#26 Dynofit

Maria Schneider · 8m spoken Josh Muccio · 6m spoken Daniel Gulati · 3m spoken Jillian Manus · 3m spoken Phil Nadel · 2m spoken James Altucher · 51s spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

Biomedical engineer Maria Schneider pitches Dynofit, an in-home physical therapy monitoring device, seeking $500,000 on The Pitch. Although investors praise the product's clinical impact and Maria's founder journey, all four pass due to concerns over software defensibility, early commercial traction, and a lack of specialized healthcare venture expertise.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Josh holds 29.8% of the talking time here. How this is scored →

Josh as informed peer 4.5 Guest teaching 3.0 Guest disagreement 2.3 Josh pushing back 3.7
05100:0010:0020:0030:001:53–4:47 · Josh as informed peer 3/10 Origin Story and Live FlexDot Product Demonstration Maria gives her origin story and conducts an interactive live demonstration of the FlexDot on Jillian. The room dynamic is collaborative and curious as investors watch real-time muscle activation on the app.4:49–9:26 · Josh as informed peer 4/10 Personal Rehabilitation Experience and Clinical Validation Phil questions why Dynofit is selling to physical therapists instead of directly to consumers at home. Maria educates the room on clinic economics, Medicare bundled payment structures, and joint implant volume projections.9:28–12:39 · Josh as informed peer 6/10 Defensibility, Patent Coverage, and the Software Dilemma Jillian strongly challenges Maria's hardware-only approach, insisting the true enterprise value lies in proprietary software and data ownership rather than third-party integrations.12:39–15:04 · Josh as informed peer 5/10 Executive Leadership Debate and Founder Capabilities Investors question whether Maria is the right long-term CEO. Maria admits she is willing to step aside eventually, prompting Daniel to push back constructively and encourage her to own her leadership.15:16–21:08 · Josh as informed peer 5/10 Investor Decisions and Formal Rejections All four investors pass in succession, citing software defensibility gaps, lack of med-device sector expertise, and early traction stage, though all praise Maria's founder capability.21:10–27:48 · Josh as informed peer 4/10 Post-Pitch Deliberation Among the Investors After investor debriefs, Josh checks in six months later. When Josh questions her modest fundraising progress, Maria reflects on healthcare sales cycles and systemic shifts in patient accountability.1:53–4:47 · Guest teaching 2/10 Origin Story and Live FlexDot Product Demonstration Maria gives her origin story and conducts an interactive live demonstration of the FlexDot on Jillian. The room dynamic is collaborative and curious as investors watch real-time muscle activation on the app.4:49–9:26 · Guest teaching 5/10 Personal Rehabilitation Experience and Clinical Validation Phil questions why Dynofit is selling to physical therapists instead of directly to consumers at home. Maria educates the room on clinic economics, Medicare bundled payment structures, and joint implant volume projections.9:28–12:39 · Guest teaching 3/10 Defensibility, Patent Coverage, and the Software Dilemma Jillian strongly challenges Maria's hardware-only approach, insisting the true enterprise value lies in proprietary software and data ownership rather than third-party integrations.12:39–15:04 · Guest teaching 2/10 Executive Leadership Debate and Founder Capabilities Investors question whether Maria is the right long-term CEO. Maria admits she is willing to step aside eventually, prompting Daniel to push back constructively and encourage her to own her leadership.15:16–21:08 · Guest teaching 2/10 Investor Decisions and Formal Rejections All four investors pass in succession, citing software defensibility gaps, lack of med-device sector expertise, and early traction stage, though all praise Maria's founder capability.21:10–27:48 · Guest teaching 4/10 Post-Pitch Deliberation Among the Investors After investor debriefs, Josh checks in six months later. When Josh questions her modest fundraising progress, Maria reflects on healthcare sales cycles and systemic shifts in patient accountability.1:53–4:47 · Guest disagreement 1/10 Origin Story and Live FlexDot Product Demonstration Maria gives her origin story and conducts an interactive live demonstration of the FlexDot on Jillian. The room dynamic is collaborative and curious as investors watch real-time muscle activation on the app.4:49–9:26 · Guest disagreement 2/10 Personal Rehabilitation Experience and Clinical Validation Phil questions why Dynofit is selling to physical therapists instead of directly to consumers at home. Maria educates the room on clinic economics, Medicare bundled payment structures, and joint implant volume projections.9:28–12:39 · Guest disagreement 4/10 Defensibility, Patent Coverage, and the Software Dilemma Jillian strongly challenges Maria's hardware-only approach, insisting the true enterprise value lies in proprietary software and data ownership rather than third-party integrations.12:39–15:04 · Guest disagreement 3/10 Executive Leadership Debate and Founder Capabilities Investors question whether Maria is the right long-term CEO. Maria admits she is willing to step aside eventually, prompting Daniel to push back constructively and encourage her to own her leadership.15:16–21:08 · Guest disagreement 2/10 Investor Decisions and Formal Rejections All four investors pass in succession, citing software defensibility gaps, lack of med-device sector expertise, and early traction stage, though all praise Maria's founder capability.21:10–27:48 · Guest disagreement 2/10 Post-Pitch Deliberation Among the Investors After investor debriefs, Josh checks in six months later. When Josh questions her modest fundraising progress, Maria reflects on healthcare sales cycles and systemic shifts in patient accountability.1:53–4:47 · Josh pushing back 1/10 Origin Story and Live FlexDot Product Demonstration Maria gives her origin story and conducts an interactive live demonstration of the FlexDot on Jillian. The room dynamic is collaborative and curious as investors watch real-time muscle activation on the app.4:49–9:26 · Josh pushing back 3/10 Personal Rehabilitation Experience and Clinical Validation Phil questions why Dynofit is selling to physical therapists instead of directly to consumers at home. Maria educates the room on clinic economics, Medicare bundled payment structures, and joint implant volume projections.9:28–12:39 · Josh pushing back 6/10 Defensibility, Patent Coverage, and the Software Dilemma Jillian strongly challenges Maria's hardware-only approach, insisting the true enterprise value lies in proprietary software and data ownership rather than third-party integrations.12:39–15:04 · Josh pushing back 5/10 Executive Leadership Debate and Founder Capabilities Investors question whether Maria is the right long-term CEO. Maria admits she is willing to step aside eventually, prompting Daniel to push back constructively and encourage her to own her leadership.15:16–21:08 · Josh pushing back 4/10 Investor Decisions and Formal Rejections All four investors pass in succession, citing software defensibility gaps, lack of med-device sector expertise, and early traction stage, though all praise Maria's founder capability.21:10–27:48 · Josh pushing back 3/10 Post-Pitch Deliberation Among the Investors After investor debriefs, Josh checks in six months later. When Josh questions her modest fundraising progress, Maria reflects on healthcare sales cycles and systemic shifts in patient accountability.

speaking balance: gold is Josh, purple is the guest (3 minute bins)

0:00 · Josh 68.4% · guest 31.6%0:00 · Josh 68.4% · guest 31.6%3:00 · Josh 50% · guest 50%3:00 · Josh 50% · guest 50%6:00 · Josh 22.8% · guest 77.2%6:00 · Josh 22.8% · guest 77.2%9:00 · Josh 7.5% · guest 92.5%9:00 · Josh 7.5% · guest 92.5%12:00 · Josh 6.3% · guest 93.7%12:00 · Josh 6.3% · guest 93.7%15:00 · Josh 3.8% · guest 96.2%15:00 · Josh 3.8% · guest 96.2%18:00 · Josh 5.3% · guest 94.7%18:00 · Josh 5.3% · guest 94.7%21:00 · Josh 36.4% · guest 63.6%21:00 · Josh 36.4% · guest 63.6%24:00 · Josh 24.8% · guest 75.2%24:00 · Josh 24.8% · guest 75.2%27:00 · Josh 71.7% · guest 28.3%27:00 · Josh 71.7% · guest 28.3%30:00 · Josh 0% · guest 0%30:00 · Josh 0% · guest 0%
Sharpest disagreement ▶ 12:21 Defending founder head start over outside CEO

Maria firmly counters the assumption that an outside executive is needed, arguing an incoming CEO would lack her three years of deep product and market insights.

 Hardest push from Josh ▶ 10:53 Jillian rejects hardware-centric strategy

Jillian directly refuses the premise that selling pure hardware sensors is sufficient, pressing Maria on lost data ownership and recurring revenue.

 Biggest teaching moment ▶ 8:25 Medicare bundled payment market breakdown

Maria educates the investors on changing Medicare reimbursement structures and orthopedic joint replacement growth, showing how clinics profit from reduced in-person hours.

 Josh holds their own ▶ 11:44 Jillian outlines data asset scale requirements

Jillian leverages her investment domain expertise to break down why hardware sensors become commoditized without integrated data capture layers.
the scores for every segment, with the reasoning behind each
ChapterTopicJosh as informed peerGuest teachingGuest disagreementJosh pushing backWhy
Origin Story and Live FlexDot Product Demonstration 3211 Maria gives her origin story and conducts an interactive live demonstration of the FlexDot on Jillian. The room dynamic is collaborative and curious as investors watch real-time muscle activation on the app.
Personal Rehabilitation Experience and Clinical Validation 4523 Phil questions why Dynofit is selling to physical therapists instead of directly to consumers at home. Maria educates the room on clinic economics, Medicare bundled payment structures, and joint implant volume projections.
Defensibility, Patent Coverage, and the Software Dilemma 6346 Jillian strongly challenges Maria's hardware-only approach, insisting the true enterprise value lies in proprietary software and data ownership rather than third-party integrations.
Executive Leadership Debate and Founder Capabilities 5235 Investors question whether Maria is the right long-term CEO. Maria admits she is willing to step aside eventually, prompting Daniel to push back constructively and encourage her to own her leadership.
Investor Decisions and Formal Rejections 5224 All four investors pass in succession, citing software defensibility gaps, lack of med-device sector expertise, and early traction stage, though all praise Maria's founder capability.
Post-Pitch Deliberation Among the Investors 4423 After investor debriefs, Josh checks in six months later. When Josh questions her modest fundraising progress, Maria reflects on healthcare sales cycles and systemic shifts in patient accountability.

Statements from this episode (14)

Assertion Not checkable as stated
Schneider: Physical therapy clinics bill $200 to $400 per session
“They're billing out two to 400 dollars this session.”
Maria Schneider Mar 3, 2025 ▶ 2:21
Assertion Not checkable as stated
Jillian Manus reveals she was paralyzed from the waist down
“I was paralyzed from my waist down about five years ago. I fell down a flight of stairs, and they didn't think I was going to be able to walk.”
Jillian Manus Mar 3, 2025 ▶ 4:50
Assertion Supported
Schneider: Traditional Electromyography Systems Tend to Cost Over $10,000
“The systems tend to cost over 10,000 dollars, so this is just a completely new packaging of a well-researched, well-understood technology.”
Maria Schneider Mar 3, 2025 ▶ 7:53
Disclosure
Schneider: Dynofit in Talks With Top Three Joint Implant Manufacturers
“So we're in conversation with the top three joint implant manufacturers right now.”
Maria Schneider Mar 3, 2025 ▶ 8:25
Prediction Open · timeframe Mar 2038
Schneider: Joint Implants Will Grow to 3.5M Annually Within 13 Years
“There's a million a year going up to 3.5 million in the next 13 years or so all over the world.”
Maria Schneider Mar 3, 2025 ▶ 8:32
Assertion Contradicted
Schneider: Joint Implants Are the Third Largest Medicare Cost Center
“It's the third largest cost center for Medicare.”
Maria Schneider Mar 3, 2025 ▶ 8:46
Insight
Manus: Software and Data Drive Value in Connected Health Devices
“The big revenue generator is the software. Okay. It's not the device. The device is purchased or licensed, but it's really the software and the data. Okay. That is the true value.”
Jillian Manus Mar 3, 2025 ▶ 10:54
Assertion Not checkable as stated
Maria Schneider argues her head start beats an experienced outside CEO
“One thing I know about myself is I have a three-year head start in thinking about this product, this market, how it can be used, talking to people about it, and getting feedback on it that even a really experienced CEO coming in today right now wouldn't have”
Maria Schneider Mar 3, 2025 ▶ 14:35
Disclosure
Manus passes on Dynofit citing lack of software defensibility
“So I'm going to say I'm going to pass for now because I have invested in medical devices and there, and this one seems, even though it's first, as you're saying, it seems it would be easy to replicate which is why I wanted the software component to it, not onl…”
Jillian Manus Mar 3, 2025 ▶ 15:50
Disclosure
Altucher passes on Dynofit without domain expert investor leading
“That said, that doesn't stop me from investing in something, but I do need someone smarter than me in the space investing, given that there's no professionals yet, ah, who are from the space in the round. I would be happy to be in if somebody else was in who k…”
James Altucher Mar 3, 2025 ▶ 20:07
Disclosure
Schneider: Dynofit has closed about 30% of $500K round
“We've gotten about 30% of that since then.”
Maria Schneider Mar 3, 2025 ▶ 25:35
Insight
Schneider: Healthcare sales cannot succeed simply by adding more salespeople
“The medical market is a little bit of a different animal, because this is not just a matter of, okay, you know, you throw enough salespeople at it of any variety, it's all gonna work out.”
Maria Schneider Mar 3, 2025 ▶ 26:01
Assertion Not checkable as stated
Host Josh Muccio reveals James Altucher ghosted the show and founders
“We never heard back from him and to our knowledge, neither have any of the founders who pitched him on our show.”
Josh Muccio Mar 3, 2025 ▶ 28:57
Disclosure
The Pitch announces it will stop airing episodes featuring James Altucher
“And this will be the final pitch we air that we recorded with him.”
Josh Muccio Mar 3, 2025 ▶ 29:06
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more